Introduction
============

Recent advances in genomic technology have allowed the efficient, large-scale characterization of gene copy-number variation in the human genome ([@b61]; [@b12]; [@b109]). Copy-number variants and polymorphisms, which can involve from one to dozens of genes, are increasingly being linked with human diseases ([@b194]; [@b131]), including neurodevelopmental conditions such as autism ([@b191]) and schizophrenia ([@b29]; [@b151]), and they are currently the subject of intense interest from medical geneticists. An important role for genomic copy-number variation in human evolution has also been postulated ([@b54]), given that about one-third of over 24 000 genes analyzed have been found to exhibit copy-number variation among species of humans and other primates ([@b54]), with humans and chimpanzees in particular differing by over 6% in their complements of genes ([@b49]). However, the roles of selection and other processes in the evolution of such differences have only recently come under scrutiny ([@b155], [@b156]; [@b35]; [@b21]; [@b109]), and such evolutionary-genomic studies have yet to focus on neurogenetic conditions underlain by variation in gene copy number.

A key feature of gene copy-number variation is that it normally engenders both deletions and duplications of the same genomic region, generating individuals with one copy or three copies of the genes involved, in addition to the usual complement of two ([@b208]; [@b176]; [@b194]; [@b13]). Such variation provides unique opportunities to analyze the phenotypic effects of variation in copy number, with naturally occurring variants that may generate reduced, normal, and increased gene expression (or other effects), depending upon the nature of the alterations involved (e.g., [@b206]; [@b133]; [@b211]; [@b144]; [@b26]). Similarly, variation in copy number for an entire chromosome is represented by Turner syndrome (45,X females) in comparison to Klinefelter syndrome (usually 47,XXY). In this case, the aneuploidies may cause variable expression of genes not subject to X inactivation, which comprise the two pseudoautosomal regions and 15--20% of other X-linked genes ([@b32]).

Diametric variation in gene copy number can generate what can be referred to as 'sister'-disorders, pairs of disorders that are mediated by directly opposite alterations to genomic regions that may result in diametric changes to gene expression or transcriptional-regulation patterns. In principle, sister-disorders might be expected to result in diametric phenotypes to the extent that genotype--phenotype mappings are relatively simple functions of gene copy number and diametric alterations to developmental-genetic pathways; for example, [@b18] reported hypoactivity versus hyperactivity in mice with the *RAI1* gene experimentally deleted versus duplicated.

Genomic and developmental alterations due to gene copy-number variation are directly analogous to diametric, large-magnitude effects due to alterations of imprinted genes, which are usually expressed from only one chromosome but when dysregulated may exhibit either doubled or absent expression ([@b192]). Genes subject to imprinting effects are expected from the kinship theory of imprinting to be involved in physiological and social--behavioral interactions between mothers and developing offspring ([@b87]), and dysregulation of such systems, toward increased relative effects from either maternal or paternal genes, can mediate the development of psychotic-spectrum versus autistic-spectrum conditions respectively ([@b42]). Alterations to genomic copy number and to imprinted gene expression may thus both lead, by different mechanisms, to large-scale, diametric changes to neurodevelopment that may provide useful insights into the genomic architecture of psychiatric disorders involving the social brain.

The purpose of this review is to synthesize recent data and compare the major human neurogenetic sister-disorders recognized and characterized to date, to assess the extent to which they exhibit diametric phenotypes with regard to aspects of cognition and behavior. To achieve this goal, we have synthesized two main sources of information from the literature: (i) data on the phenotypes associated with the four best-known human genomic sister-disorders, and (ii) data on linkages of the genes involved to psychiatric conditions. We also conducted the first tests of positive selection (adaptive evolution) for the genes salient to these syndromes, under the hypothesis that positively selected genes or haplotypes in these regions have, historically, exhibited functional phenotypic effects on neurodevelopment, cognition and behavior that make them especially strong positional and functional candidates for the causes of variation in social--cognitive phenotypes observed across pairs of sister-disorders. Examples of genes exhibiting variants that affect cognition and psychiatric phenotypes, as well as showing evidence for recent positive selection in humans, include *FOXP2* ([@b62]), *EFHC2* ([@b233]), and *MCPH1* ([@b64]; [@b119]), as well as positively selected genes underlying schizophrenia ([@b43]). Most generally, this study is intended to facilitate the integration of evolutionary principles and methods into analyses of the genetic and genomic bases for human neurocognitive disorders and the architecture of nonclinical cognitive and behavioral phenotypes.

Methods
=======

Literature review
-----------------

PubMed and Web of Science were searched using the names of specific known syndromes, and the terms 'deletion' and 'duplication' in conjunction with the names, genomic locations, and genes associated with the syndromes analyzed. Psychiatric and behavioral phenotypes associated with these syndromes and regions were searched using syndrome names, genomic regions, and genes, in conjunction with the names of the major psychiatric conditions. We also used the schizophrenia gene database ([@b2]) and Sullivan laboratory evidence project database ([@b108]), to collect and synthesize evidence regarding the genetic bases of psychiatric phenotypes.

Analyses of positive selection
------------------------------

We used two measures of positive selection for the genes involved in the neurogenetic syndromes analyzed here: the iHS statistic developed by [@b229], which quantifies the probabilities of recent selective sweeps for given genes and regions of the genome from human HapMap data, and the branch-site likelihood ratio tests of branch-site models implemented in PAML ([@b243]), which allows inference of adaptive protein evolution. Methods in PAML followed those in [@b43], and we tested for selection along the human lineage, the human--chimp stem lineage, and the lineage at the origin of primates (the ancestral primate lineage leading to Catarhinni, including Old World monkeys, lesser apes and great apes), as these lineages exhibit phenotypic changes that we consider most salient to the evolution of social cognition.

Results
=======

The primary genetic, genomic, and phenotypic features of the syndromes analyzed here are summarized in [Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"}. We describe each pair of sister-syndromes, summarize the evidence for positive selection on the genes involved, and synthesize the available information.

###### 

Genomic sister-disorders of human growth, development, cognition and behavior, with descriptions of their genetic bases

  Syndrome name or description           Primary genomic alteration and genes implicated
  -------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Smith--Magenis                         Hemizygous deletion of region at 17p11.2 including *RAI1* gene; *RAI1* mutations ([@b85])
  Potocki--Lupski                        Duplication of Smith--Magenis region ([@b172])
  VCFS region deletion                   Deletion of ∼30 genes at 22q11.2, effects from *COMT, DGCR2, GNB1L, TBX1, UFD1L*, other genes ([@b78]; [@b133])
  VCFS region duplication                Duplication of 22q11.2 region ([@b150])
  Williams-syndrome region deletion      Hemizygous deletion of over 25 genes at 7q11.23; effects from *CYLN2, GTF2I, GTF2IRD1, LIMK1*, other genes ([@b219]; [@b84]; [@b58]; [@b242])
  Williams-syndrome region duplication   Duplication of 7q11.23 region ([@b14])
  Klinefelter                            One or more excess X chromosomes; Increased expression of PAR1, PAR2 genes and other non X-inactivated genes ([@b48]; [@b226])
  Turner                                 All or part of X chromosome lost ([@b216]); haploinsufficiency of PAR1, PAR2 genes and other non X-inactivated genes ([@b126]); neurocognitive phenotype maps to Xp22.3 ([@b245])

###### 

Genomic sister-disorders categorized into two groups, each of which shares a suite of partially overlapping phenotypic traits

  Psychotic-spectrum syndromes                                                                                                                                           Autistic-spectrum syndromes
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------
  Smith--Magenis                                                                                                                                                         Potocki--Lupski
   High levels of sociability ([@b204]; [@b189])                                                                                                                         High rates of autism and autistic behavior ([@b147]; [@b172])
   Relative strength in verbal skills ([@b56])                                                                                                                           
   Case reports of 'bipolar episodes' ([@b74])                                                                                                                           
   Case report of mood disorder ([@b16])                                                                                                                                 
  Velocardiofacial                                                                                                                                                       Velocardiofacial-region duplications
   Better verbal than visual--spatial skills ([@b10]; [@b114])                                                                                                           Hyperactivity, attention deficits, anxiety, depression, seizures, speech problems, impulsivity ([@b63]; [@b241]; [@b1])
   High rates of schizophrenia, schizoaffective disorders, bipolar, depression, anxiety, phobia ([@b78])                                                                 Case report of autism ([@b150])
                                                                                                                                                                         Case report of Asperger syndrome ([@b89])
                                                                                                                                                                         Two cases of autism ([@b127])
                                                                                                                                                                         Two cases of autism (Christian et al. 2008)
  Williams                                                                                                                                                               Williams-region duplications
   Better verbal than visual--spatial skills ([@b227])                                                                                                                   Severe language impairment, visual-spatial skills spared ([@b14])
   Hypersociability, fascination with faces ([@b53])                                                                                                                     High rates of autism and autistic behavior ([@b14]; [@b50])
   Dyslexia ([@b220])                                                                                                                                                    
   High rates of anxiety and phobias ([@b141]; [@b123])                                                                                                                  
  Klinefelter                                                                                                                                                            Turner
   Dyslexia ([@b72])                                                                                                                                                     Hyperlexia ([@b221])
   Poor verbal skills, preserved visual- spatial skills ([@b146]; [@b48])                                                                                                Good verbal skills, impaired visual- spatial skills ([@b146]; [@b103])
   High rates of schizophrenia, schizoaffective disorder, schizotypy, bipolar disorder, anxiety, depression ([@b48]; [@b182]; [@b20])[\*](#tf2-1){ref-type="table-fn"}   Gaze aversion ([@b116])
                                                                                                                                                                          High rates of autism and autistic traits in maternal-X cases ([@b203])
                                                                                                                                                                          Reduced incidence of schizophrenia plus bipolar disorder ([@b148])
  Idiopathic schizophrenia                                                                                                                                               Idiopathic autism
   Low birth weight ([@b231]; [@b160])                                                                                                                                   High or average birth weight ([@b188];[@b149]; [@b212])
   Slow growth ([@b157]) Small head, brain size ([@b86])                                                                                                                 Overgrowth, faster body growth ([@b51]; [@b142]; [@b149]; [@b71])
   Better verbal than visual--spatial skills ([@b110])                                                                                                                   Macrocephaly ([@b113]; [@b207])
   Dyslexia ([@b15]; [@b179])                                                                                                                                            Hyperlexia ([@b154])
   Overlap in genetic basis with bipolar disorder, major depression, and schizotypy ([@b38]; [@b224]; [@b19]; [@b67]; [@b171]                                            Better visual--spatial than verbal skills in subset of cases ([@b31])

'Psychotic-spectrum' syndromes involve an increased incidence of psychotic-spectrum psychiatric conditions (mainly schizophrenia, schizoaffective disorder, bipolar disorder, depression, anxiety, and phobias), and 'autistic-spectrum' syndromes involve autistic traits, autism and Asperger syndrome.

Two case studies have described autism or autism-spectrum disorders (PDD-NOS) in Klinefelter individuals ([@b97]; [@b137]). These cases were characterized by speech delay and introversion, with no evidence of restricted interests or motor stereotypies in the four children described.

Smith--Magenis and Potocki--Lupski syndromes
--------------------------------------------

Smith--Magenis syndrome is caused by a microdeletion of about 3.7 Mb at 17p11.2, or by mutations in the gene *RAI1* (retinoic acid inducible 1), the gene believed to underlie most of the behavioral, neurological and craniofacial traits found in this condition ([@b205]; [@b17]; [@b74]; [@b60]) ([Table 1](#tbl1){ref-type="table"}). Potocki--Lupski syndrome, due to duplication of this same region, has recently been identified and described ([@b172]) and it appears to be due predominantly to increased copy number of *RAI1* ([@b144]).

### Smith--Magenis syndrome

Behavioral and cognitive characteristics that have been described for Smith--Magenis syndrome include generalized complacency and lethargy in infancy, speech delay, stereotypies that involve self-hugging and 'licking and flipping' the pages of books, hyperactivity, impulsivity, aggression, self-injury, skin picking, mood lability, and a friendly, affectionate personality ([@b195]; [@b205]; [@b74]; [@b129]; [@b85]). Traits ascribed to this condition also include a high level of social attention-seeking and friendliness with strangers, high sensitivity and irritability ([@b189]), decreased sensitivity to pain ([@b195]; [@b17]), high sociability as infants, with appealing smiles and lack of crying, and good eye contact and sense of humor as children ([@b204]). Individuals with Smith--Magenis syndrome exhibit moderate to severe mental retardation ([@b189]), with a relative strength in verbal skills, but relatively weak sequential processing abilities ([@b56]).

The psychiatric phenotypes associated with Smith--Magenis syndrome include a case report of 'mood disorder' involving extreme mood shifts, depression and 'explosive behavior' ([@b16]), a case report of Tourette\'s syndrome ([@b196]), and three cases of Smith--Magenis syndrome due to *RAI1* point mutations that involved 'bipolar episodes' in two individuals, and 'explosive tantrums' in another. Genome-scan studies have linked the 17p11.2 region with a variety of disorders, including schizophrenia ([@b235]; [@b27], [@b28]), attention-deficit/hyperactivity disorder (ADHD) ([@b162]) and autism ([@b222]; [@b240]), and cytogenetic anomalies of this region have been associated with autism ([@b115]; [@b230]). Variation in the number of CAG repeats in the *RAI1* gene has been linked with drug responses in schizophrenics, but these variants were not associated with schizophrenia itself ([@b99]). However, polymorphisms in the two genes immediately proximal and distal to *RAI1*, *PEMT* and *SREBF1,* have recently been linked with schizophrenia ([@b125]; [@b118]).

### Potocki--Lupski syndrome

Potocki--Lupski syndrome is characterized by failure to thrive in infancy, developmental delay, speech impairments including absent speech, echolalia (repetition of heard speech), verbal apraxia, mild mental retardation, autistic features, epileptiform EEG, seizures, and hyperactivity ([@b75]; [@b172]). Two individuals with this syndrome were formally diagnosed with autism ([@b147]; [@b172]), and specific autistic features that have been described include decreased eye contact, motor mannerisms, sensory hypersensitivities or preoccupations, and repetitive behavior ([@b172]). [@b172] suggested that nearly all patients with this syndrome exhibited features of autism spectrum disorders.

### Evidence of positive selection

Using PAML, the *RAI1* gene was inferred as subject to positive selection for the primate-origin lineage ([Table 3](#tbl3){ref-type="table"}), but not in the human or human--chimp lineages, nor in the human HapMap data.

###### 

Evidence for positive selection on genes associated with human neurogenetic sister-disorders, from maximum likelihood analyses

  Gene                                                             Gene symbol   Lineage   −2ΔLn                                                                    Positively selected codons (posterior probability)
  ---------------------------------------------------------------- ------------- --------- ------------------------------------------------------------------------ ----------------------------------------------------
  Pseudoautosomal region 1                                                                                                                                          
   *Interleukin 3 receptor, alpha*                                 *IL3RA*       Primate   5.32[\*](#tf3-1){ref-type="table-fn"}                                    None
   *GTP binding protein 6*                                         *GTPBP6*      Primate   8.04[\*](#tf3-1){ref-type="table-fn"}[\*](#tf3-1){ref-type="table-fn"}   Leu 125 (0.982)
   *Acetylserotonin O-methyltransferase-like*                      *ASTML*       Primate   6.20[\*](#tf3-1){ref-type="table-fn"}                                    None
   *Purinergic receptor P2Y, G-protein coupled, 8*                 *P2R8Y*       Primate   9.82[\*](#tf3-1){ref-type="table-fn"}[\*](#tf3-1){ref-type="table-fn"}   None
  Velocardiofacial syndrome                                                                                                                                         
   *claudin 5*                                                     *CLDN5*       Primate   6.70[\*](#tf3-1){ref-type="table-fn"}[\*](#tf3-1){ref-type="table-fn"}   None
   *Guanine nucleotide binding protein, beta polypeptide 1-like*   *GNB1L*       Primate   4.86[\*](#tf3-1){ref-type="table-fn"}                                    Ser 119 (0.961)
   *Zinc finger protein 74*                                        *ZNF74*       Primate   9.94[\*](#tf3-1){ref-type="table-fn"}[\*](#tf3-1){ref-type="table-fn"}   Ala 84 (0.961) Thr 321 (0.991)
   *Catechol-O-methyltransferase*                                  *COMT*        Primate   8.02[\*](#tf3-1){ref-type="table-fn"}[\*](#tf3-1){ref-type="table-fn"}   Pro 324 (0.972)
   *Ubiquitin fusion degradation 1 like*                           *UFD1L*       Human     6.58[\*](#tf3-1){ref-type="table-fn"}                                    His 221 (0.983)
  Smith--Magenis syndrome                                                                                                                                           
   *Retinoic acid induced 1*                                       *RAI1*        Primate   5.68[\*](#tf3-1){ref-type="table-fn"}                                    None
  Williams syndrome                                                                                                                                                 
   *Replication factor C 2*                                        *RFC2*        Primate   3.78                                                                     None

We focused on putatively causative genes where these were known from studies of single-gene mutations or atypical deletions (in Williams syndrome and Smith--Magenis syndrome), but where the causative genes were unknown (for Klinefelter, Turner, and Velocardiofacial syndromes) we analyzed all of the genes in the affected regions.

*P* \< 0.05, [\*](#tf3-1){ref-type="table-fn"}[\*](#tf3-1){ref-type="table-fn"}*P* \< 0.01.

### Synthesis

Smith--Magenis and Potocki--Lupski syndromes are clear genomic sister-disorders that appear to exhibit diametric phenotypes with regard to sociability and verbal abilities. Although Potocki--Lupski syndrome is strongly associated with autism, the behavioral phenotype and psychiatric correlates of Smith--Magenis syndrome have yet to be analyzed systematically, although they appear to involve high levels of sociability and a high incidence of dysregulated mood. The presence of positive selection for the *RAI1* gene in the primate-origin lineage is notable given that only seven of 120 randomly chosen 'control' genes involved in neurological functions have shown evidence of selection on this lineage ([@b43]).

Velocardiofacial syndrome and duplications of the VCFS region
-------------------------------------------------------------

Velocardiofacial syndrome (VCFS) involves congenital malformation of the heart, face and limbs, usually due to a 3-Mb deletion at 22q11.2 that contains over 30 genes ([@b69]; [@b130]; [@b78]; [@b107]; [@b82]; [@b173]). A syndrome mediated by duplication of this region has recently been recognized, and is being better-characterized as more cases accumulate ([Table 2](#tbl2){ref-type="table"}).

### Velocardiofacial syndrome

Velocardiofacial syndrome involves mild mental retardation, impaired language development, motor skills, and verbal working memory, and especially limited abilities in reading comprehension, visual--spatial tasks and mathematics, in contrast to relatively well-preserved verbal skills ([@b10]; [@b159]; [@b198],[@b199]; [@b244]; [@b114]). The behavioral phenotype of VCFS patients in childhood and early adolescence involves withdrawal, shyness, impulsiveness, inattentiveness ([@b57]), emotional lability, angry outbursts, and high scores on scales of schizotypy ([@b8]), and anxiety, depression, social withdrawal and psychotic episodes (mainly auditory hallucinations) ([@b46]). In adolescence and adulthood, about 30% of VCFS patients are diagnosed with schizophrenia, of a form with a relatively high incidence of positive symptoms ([@b152]; [@b228]). This syndrome thus represents the most common genetic alteration known to mediate risk of schizophrenia ([@b9]), and one of the most penetrant causes of schizophrenia. VCFS also demonstrates notable similarities to schizophrenia in overall neurocognitive profile ([@b34]; [@b121]), and brain structure in VCFS appears similar to that found in schizophrenia in some respects ([@b80],[@b81], [@b82]). [@b78] describes the wider psychopathological profile of VCFS patients, as involving high rates of schizophrenia and schizoaffective disorder, bipolar disorder, depression, dysthymia, phobias, obsessive--compulsive disorder, generalized anxiety disorder, panic disorder, ADHD, pervasive developmental disorder -- not otherwise specified (PDD-NOS), and psychotic symptoms. VCFS has also been associated with autism spectrum conditions (e.g., [@b6]; [@b101]), but such diagnoses appear to be based on superficial psychological similarities of autism or PDD-NOS with schizotypy and negative symptoms of schizophrenia, that are not underlain by biological evidence ([@b59]; [@b68]; [@b42]; [@b213]).

Many of the physical features of VCFS are apparently mediated by haploinsufficiency of the *TBX1* gene ([@b165]; [@b248]), and several genes in the deletion region, notably *COMT, DGCR2, GNB1L, ProDH2*, *UFD1L* have been implicated in liability to schizophrenia among individuals without VCFS syndrome ([@b124]; [@b5]; [@b79]; [@b238]; [@b197]; [@b2]; [@b173]; [@b236]). Given that over 30 genes are commonly deleted in this syndrome, the physical and psychiatric phenotypes appear to be mediated by reduced expression of multiple genes, whose relative importance for different phenotypes remains to be elucidated ([@b133]).

### VCFS-region duplications

About 30 cases of duplications of the VCFS region have thus far been reported ([@b150]). These duplications are associated with phenotypes that include some combination of hyperactivity, attention deficits, learning disability, speech delays, impulsivity, seizures, and aggressive behavior ([@b88]; [@b170]; [@b241]; [@b1]; [@b150]). This condition appears milder, more variable, and less distinctive than VCFS ([@b112]; [@b37]; [@b164]), and it has not been ascertained independently of other conditions, although the duplication was found in two of 275 females referred for fragile X testing ([@b241]).

[@b150] presented a case report of severe autism associated with this duplication, with minimal speech, stereotypic behavior, and lack of eye contact, joint attention or play; the father of this patient exhibited the same duplication, and was described as introverted, obsessive and learning disabled. [@b89] diagnosed a case of Asperger syndrome in an individual with this region duplicated, and [@b127] and [@b501] each reported two cases of autistic individuals with the duplication. Although schizophrenia risk is increased ∼30-fold in 22q11.2 deletion cases, a recent study reported no cases of 22q11.2 duplications in a sample of 190 patients with schizophrenia ([@b25]).

### Evidence of positive selection

Maximum-likelihood analyses detected four genes (of 29 analyzed) in the 3 Mb typically deleted VCFS region as subject to positive selection in the primate-origin lineage ([Table 3](#tbl3){ref-type="table"}). This proportion of genes inferred as selected (13.8%) is higher than the proportion selected (5.8%) on this lineage among 120 'control' neurological-function genes ([@b43]) but not significantly so (χ^2^ = 2.16, *P* = 0.14). One gene, *UFD1L*, showed evidence of selection along the human lineage. Of the five total genes inferred as selected with maximum likelihood, four of them (*CLDN5*, *COMT*, *GNB1L*, and *UFD1L*) have been associated with schizophrenia in one or more study ([@b2]; [@b236]).

Genes showing HapMap evidence of selection (*P* \< 0.05 in one or more of the three populations) in recent human ancestry include *DGCR6* and a block of contiguous genes spanning *HIRA, MRPL40, UFD1L, CDC45L*, and *CLDN5*, with the former four of these genes showing evidence of selection for all three populations, which is very rare for HapMap-based selection studies ([@b229]).

### Synthesis

Velocardiofacial syndrome is strongly associated with schizophrenia and related disorders, and the genetic and neuroanatomical correlates of these conditions. The phenotypes associated with VCFS-duplication syndrome are only now emerging, and robust evaluation of the behavioral and psychiatric features in this syndrome requires standardized study of a substantial number of cases. However, the association of autism with VCFS-region duplications in multiple studies is striking, and should motivate analyses that further evaluate the presence of autism-associated biological traits (such as macrocephaly and seizures) and well as cognitive profiles and formal DSM criteria.

Three lines of evidence: (i) the notable proportion of VCFS-region genes inferred as subject to positive selection for the primate-origin lineage, (ii) the HapMap selection signal across a block of genes in three populations, and (iii) the finding that one schizophrenia-associated gene, *UFD1L*, shows evidence of positive selection for the human lineage from both HapMap and PAML analyses, suggest that some of the genes underlying the phenotypic effects of VCFS have undergone primate-specific and human-specific adaptive evolution with functional relevance to the etiologies of schizophrenia and autism.

Williams syndrome and Williams-syndrome region duplications
-----------------------------------------------------------

Williams syndrome is typically caused by deletion of a region of 7q11.23 that includes 25--30 genes ([@b219]), although analyses of atypical deletions have shown that a small subset of these genes is sufficient to elicit the main phenotypic traits involved. This deletion is mediated by low-copy-repeats that flank this region ([@b4]), which also cause duplications that have recently been identified and characterized with regard to their phenotypic effects ([@b14]; [@b50]; [@b105]).

### Williams syndrome

Williams syndrome is characterized by a suite of behavioral and cognitive features that include hypersociality and inappropriate social engagement of strangers, fascination with faces and enhanced gazing into faces, hyperverbal speech with a relative strength in vocabulary and social--emotional language, increased empathy and acute attentiveness to the emotional states of others, and increased attention-seeking and affectionate behavior ([@b167]; [@b53]; [@b68]; [@b70]; [@b169]; [@b128]).

Expressive language has been considered to be a notable relative strength in Williams syndrome, although the degree to which aspects of this trait are selectively enhanced, relative to IQ-matched controls, remains unclear ([@b141]; [@b24]). However, verbal skills are clearly much better than visual--spatial abilities, which are selectively and strongly deficient ([@b218]; [@b178]; [@b227]; [@b168]). The overall cognitive profile of Williams syndrome has been described as similar to that found in VCFS, especially with regard to visual--spatial deficits but relatively spared verbal skills ([@b11]).

Williams syndrome is also characterized by a set of behavioral and cognitive phenotypes related to psychiatric disorders, although few studies have addressed the issue of formal diagnoses of such disorders. Thus, [@b167] noted high levels of anxiety, worry, preoccupation, crying and fearfulness, as well as depressive symptoms, in Williams syndrome individuals, and [@b55], [@b122] and [@b141] describe substantially elevated rates of anxiety and phobias. In a study of 4--18 years olds, about 50% of individuals met DSM criteria for specific phobia ([@b122]) and frequencies of diagnosis were also high for ADHD (65%) and generalized anxiety disorder (12%).

The presence of autism spectrum disorders in Williams syndrome is controversial ([@b123]; [@b180]). There have been several case reports of autism diagnoses in individuals with this syndrome ([@b92]; [@b106]), and both conditions can involve impaired pragmatics of language, unusual interests, impaired development of pointing and gesturing, and difficulties in forming and maintaining social relationships ([@b117]; [@b70]; [@b106]). However, theory of mind skills has been reported as comparable to matched controls in Williams syndrome, and levels of empathy appear to be elevated above controls ([@b214]; [@b218]). These findings, and such traits as fascination with faces and selective attention to social stimuli in Williams syndrome ([@b98]; [@b139]), and the relative strengths in visual--spatial skills reported for autistics ([@b30], [@b31]), have motivated the hypothesis that Williams syndrome and autism represent neurocognitive opposites ([@b166]). These views can be reconciled by considering the usual Williams syndrome neurocognitive profile as involving a mosaic of behavioral traits, some of which are not uncommon on the autism spectrum while others are strikingly nonautistic ([@b123]).

Neuroanatomical contrasts between idiopathic autism and Williams syndrome that may be relevant to neurocognition include overall brain size smaller in Williams syndrome ([@b33]) but larger on average in autism (e.g., [@b188]), disproportionate reductions in white matter in Williams syndrome ([@b177]) but increases in autism ([@b91]), and a cerebellar vermis that is larger in Williams syndrome ([@b190]) but smaller in autism ([@b102]). Additional biological evidence salient to autism and other psychiatric disorders in Williams syndrome is the presence, in the region that directly flanks the typical deletion and may show reduced gene expression as an apparent result ([@b138]), of the *AUTS2* gene, which exhibits mutations and a breakpoint associated with mental retardation and autism ([@b100]), and an SNP, D7S1816, strongly linked to lithium-responsive bipolar disorder in a genome scan ([@b223]). This latter finding is of notable interest given that social impulsiveness and disinhibition, mediated in part by orbitofrontal cortex abnormalities, represent a prominent phenotype in both bipolar disorder and Williams syndrome ([@b3]; [@b140]; [@b169]). One gene in the Williams-syndrome region, *STX1A*, exhibits genetic variants that have been associated with schizophrenia ([@b237]); moreover, elevated expression of the *STX1A* gene, as well as a positive genetic association, has been reported for autism ([@b153]).

Genes in the Williams syndrome region that appear to be associated with core aspects of its neurocognitive profile, based on genotype--phenotype associations of variable-size deletions, mouse mutants for specific genes, and knowledge of gene function, include *CYLN2, Gtf2I, Gtf2IRD1*, and *LIMK1* ([@b93]; [@b84]; [@b58]; [@b242]). Taken together, these studies suggest that several genes are involved, and affect different cognitive features of Williams syndrome: reduced copy-number of *Gft2RD1* has been implicated in decreased fear and increased social behavior in a mouse model ([@b242]), *LIMK1* hemizygous mice exhibit impairments in spatial abilities ([@b136]), and both *CYLN2* and *LIMK1* hemizygous mice exhibit impaired learning ([@b93]).

### Williams syndrome-region duplications

[@b14] reviewed the phenotypic features of the 10 individuals reported thus far with duplications of the Williams syndrome region, who were ascertained by developmental delays. Weight, growth and length were highly variable, but three of seven individuals measured were at or above 90% percentile in head circumference; three of 10 individuals also exhibited seizures. All 10 cases involved severe to moderate speech delay and mental retardation, but visual--spatial abilities were reported as spared in the five individuals evaluated for this phenotype ([@b14]). Four of seven individuals with behavioral information available showed stereotyped or repetitive behavior, and two of four individuals administered the ADOS met or exceeded the cutoff for ASD or autism. In previous case studies, [@b105] reported a case of 'suspected Asperger syndrome', and [@b50] reported a case of autism identified from screening 206 patients with autism spectrum disorders for this duplication. Among cases described to date, [@b163] noted striking variability in phenotype, including good social skills in several individuals, but severe language delay as a highly consistent symptom.

### Evidence of positive selection

None of the seven genes analyzed spanning *GTF2*I to *LIMK1* demonstrated statistical significance in maximum-likelihood analyses, although *RFC2* showed borderline nonsignificance (0.05 \< *P* \< 0.06) for the primate-origin lineage ([Table 3](#tbl3){ref-type="table"}). None of the genes showed gene-wide evidence of selection in the HapMap analyses. Haploinsufficiency of *RFC2* causes impaired *ATR*-mediated DNA damage response in Williams-syndrome cell lines, indicating that this gene may be responsible in part for the microcephaly and developmental delays found in Williams syndrome ([@b161]).

### Synthesis

[@b206] and [@b14] noted that the contrasting effects of deletions versus duplications for the Williams syndrome region provide evidence for strong effects of quantitative gene dosage variation on human language, sociality, and visual--spatial abilities. Expressive language in particular appears to be relatively spared (compared to other cognitive functions) in Williams syndrome deletions, but it is strikingly impaired in individuals with duplications for this region. The genetic basis of these contrasting phenotypes remains unclear, but to the extent that the variation in gene expression of *GTF2IRD1* modulates the observed effects on social--behavioral phenotypes in humans and mice ([@b242]), it represents a strong functional candidate as a gene whose over-expression can cause autism and associated deficits in the development of language. Our inference of possible selection on the *RFC2* gene also suggests that this gene, thus far neglected in studies of Williams syndrome, may play a role in the evolution of primate neurodevelopment, brain size evolution, and in the etiology of this syndrome.

X chromosome aneuploidies
-------------------------

The most common human disorders involving sex chromosome are Turner syndrome (usually 45,X, or a mosaic of 45,X and 46,XX) in females ([@b77]; [@b186]), and Klinefelter syndrome (usually 47,XXY) in males ([@b200]) ([Table 1](#tbl1){ref-type="table"}). Phenotypic effects of copy-number variation for genes on the X chromosome are also mediated by whether genes are X-inactivated: genes in both pseudoautosomal regions of the X, and about 15--20% of other genes on this chromosome, are not X-inactivated ([@b32]), and should thus exhibit variable expression levels between 45,X, 46,XX, 46,XY, and 47,XXY individuals.

### Turner syndrome (45,X)

The neurocognitive profile of adults with Turner syndrome is characterized by three main features: (i) normal or enhanced verbal skills, especially with regard to reading level, accuracy and comprehension, including a relatively high incidence of hyperlexia, (ii) notable impairments of visual--spatial skills as assayed, for example, via tests of mental rotation, block design, object assembly and mathematical ability, and (iii) impaired social skills ([@b146]; [@b221]; [@b116]; [@b158]; [@b145]; [@b220]; [@b103]).

In addition to the traits described above, the behavioral profile of Turner syndrome females also involves high rates of impulsivity, hyperactivity and inattentiveness ([@b187]), and social anxiety ([@b103]). Turner syndrome females also commonly exhibit a set of behavioral and neurocognitive phenotypes including poor peer relationships, joint attention deficits, and reduced ability to interpret social cues ([@b52]), gaze aversion ([@b116]) and impaired recognition of fear ([@b116]; [@b233]). This syndrome has also been reported to involve a significantly lower incidence of schizophrenia and bipolar disorder (considered together) ([@b148]) and a greatly increased risk of autism ([@b203]; [@b201], [@b202]).

### Klinefelter syndrome (47,XXY)

Klinefelter syndrome is associated with infantile hypotonia, hypogonadism, cryptorchidism, low birth weight, reduced length, and small head size, but increased adult height ([@b225]; [@b174], [@b175]; [@b23]; [@b184]; [@b73]). The neurocognitive profile of Klinefelter syndrome is characterized by selective impairment of verbal abilities, especially in language processing, reading, and working verbal memory, with visual--spatial abilities relatively spared ([@b83]; [@b72]; [@b22]; [@b66]; [@b95], [@b96]; [@b200]; [@b48]). [@b146] described this profile as the neurocognitive opposite of that found in Turner syndrome, with the core deficit in Klinefelter syndrome attributable to impaired 'mental processing of sequence and synchrony in the temporal dimension, including the temporal dimension of language' and [@b22] suggested that such verbal, left-hemisphere deficits are related to slow early brain development.

Psychiatric conditions associated with Klinefelter syndrome include anxiety, depression, bipolar disorder, schizoaffective disorder and schizophrenia ([@b143]; [@b47], [@b48]; [@b65]; [@b182], [@b183]; [@b20]). Several studies have demonstrated that schizophrenia in particular shows a high prevalence in Klinefelter syndrome, with a four- to 10-fold increase ([@b47], [@b48]; [@b183]). In contrast, [@b148] reported similar rates of schizophrenia and bipolar disorder in Klinefelter syndrome compared to controls, and they attributed the results of [@b47] to unspecified sampling biases. [@b48] also noted that the neurocognitive profiles are similar in Klinefelter syndrome and idiopathic (cause-unknown) schizophrenia, and [@b183] showed that Klinefelter individuals scored significantly higher than controls on scales of schizotypy. Klinefelter syndrome also involves an uneven profile of hyperfunctional emotional experience and reactivity, but impaired ability to identify and verbalize emotions, which resembles the pattern seen in schizophrenics ([@b182], [@b183]).

### Genetic basis of sex-chromosome aneuploidy phenotypes

The Turner syndrome neurocognitive phenotype of visual--spatial deficits with preserved or enhanced verbal skills has been mapped to Xp22.3, in pseudoautosomal region 1 (PAR1) ([@b185]; [@b245]). A strong positional and functional candidate for a gene in this region underlying at least one aspect of the Turner syndrome neurocognitive phenotype, and the contrasting pattern in Klinefelter syndrome of verbal deficits but spared visual--spatial abilities, has been identified by [@b226]. These authors compared gene expression in 47,XXY versus 46,XY individuals, and found that the gene *GTPBP6*, in PAR1 at Xp22.33, exhibited significantly higher expression in 47,XXY males, and that within Klinefelter patients, higher expression of this gene was associated with significantly reduced verbal skills.

The altered rates of schizophrenia and autism in individuals with sex chromosome aneuploidies implicate the effects of non-inactivated X-linked genes, or XY homologous genes, in these disorders. This hypothesis is supported by recent linkage of two loci in PAR1 (and the Turner syndrome neurocognitive region) with these neurodevelopmental disorders: the *CSF2RA-IL3RA* locus shows allelic variants associated with schizophrenia ([@b120]; [@b215]), and the *ASMT* gene bears variants associated with autism ([@b135]).

### Evidence of positive selection

We used maximum-likelihood analyses to test for positive selection on 20 genes in PAR1, as this region has been implicated in the phenotypic effects of Turner and Klinefelter syndromes. Positive selection was inferred for four genes, *ASMTL, GTPBP6, IL3RA*, and *P2RY8*, all on the primate-origin lineage ([Table 3](#tbl3){ref-type="table"}). This proportion of genes inferred as selected (20%) is significantly higher than the proportion selected (5.8%) on this lineage among 120 'control' neurological-function genes ([@b43]) (χ^2^ = 5.03, *P* = 0.025).

### Synthesis

Turner syndrome and Klinefelter syndrome demonstrate a clear diametric contrast with regard to verbal and visual--spatial skills, with Turner syndrome characterized by good verbal skills but greatly impaired visual--spatial abilities and Klinefelter syndrome individuals impaired verbally but with visual--spatial abilities spared ([@b146]; [@b48]). These syndromes also involve notably different associations with psychiatric disorders, as Turner syndrome individuals exhibit an elevated incidence of autism and autistic traits, but Klinefelter syndrome involves increased rates of schizophrenia and related disorders. The localization of genetic effects on verbal skills, visual--spatial skills, and some psychiatric disorders to non-inactivated X-linked genes suggest that altered dosages of such genes underlie the contrasting neurocognitive phenotypes of Turner and Klinefelter syndromes. These findings have important implications for the evolution of sexual dimorphism as well as the developmental and neurological bases of neurogenetic syndromes, as non-inactivated X-linked genes are expected to differ in dosage between males and females ([@b39]; [@b45]; [@b40]).

The inference of positive selection on PAR1-region genes that influence verbal ability (*GTPBP6*, [@b226]) and schizophrenia risk (*IL3RA*, [@b120]; [@b215]) is striking, especially given that *IL3RA* is the only PAR1 gene thus far implicated in schizophrenia. The function of the *ASMTL* gene remains unclear, but part of this gene is highly homologous with the autism-associated gene *ASMT* ([@b181]; [@b135]).

Discussion
==========

Genomic sister-disorders provide unique opportunities to assess the roles of gene copy-number variation in human development and disease. For the set of neurogenetic sister-disorders analyzed here, the clearest overall pattern is that one of the pairs has been commonly associated with autism spectrum conditions ([Table 2](#tbl2){ref-type="table"}), a finding that concurs with the results of recent studies showing that a notable proportion of cases of autism can be ascribed to the effects of copy-number variants ([@b191]; [@b501]; [@b127]; [@b134]; [@b502]). In contrast, the sister-disorders of the autism-associated conditions noted in [Table 2](#tbl2){ref-type="table"} appear to involve a suite of phenotypic traits that are characteristic of what has been termed the schizophrenia spectrum or psychotic spectrum, which is exemplified by the set of psychological and psychiatric conditions described for VCFS by [@b78], [Table 2](#tbl2){ref-type="table"}), as well as for Klinefelter syndrome ([@b143]; [@b65]; [@b48]; [@b182], [@b183]; [@b20]); these conditions include schizophrenia, schizoaffective disorder, bipolar disorder, unipolar depression, schizotypy, phobias, generalized anxiety disorder, panic disorders, and psychotic symptoms. The former five conditions have been demonstrated to exhibit strong patterns of overlap with regard to their genetic underpinnings ([@b38]; [@b171]; [@b224]; [@b19]; [@b67]), and rates of comorbidity of anxiety and phobias with schizophrenia, schizoaffective disorder, and bipolar disorder are on the order of 40--60% ([@b36]; [@b94]; [@b247]). As for autism, the etiology of schizophrenia is mediated, to a notable degree, by copy-number variation across a considerable number of genomic regions ([@b29]; [@b151]).

The inference that pairs of neurogenetic sister-disorders tend to involve autistic-spectrum versus psychotic-spectrum phenotypes implies that human cognitive architecture may be structured along a continuum of social brain development from hypo-development in autism, to so-called normality, to hyper-development in psychosis, which is revealed most clearly by diametric perturbations to genes affecting development and evolution of the social brain ([@b42]). Evidence of such a pattern has also been reported for perturbations that involve genomic imprinting, which are expected under the kinship theory of imprinting ([@b87]) to involve social interactions and social brain development ([@b41]; [@b42]). The pattern for copy-number effects described here suggests that not only relatively well-known neurogenetic sister-disorders, but also disorders due to smaller-scale and less well-characterized copy-number polymorphisms or variants, may mediate similarly contrasting cognitive and psychiatric phenotypes. More generally, primate and human evolution has presumably involved the selective accumulation of alleles mediating development of an increasingly complex and sophisticated social brain, which in humans may be perturbed toward either hypo-development in autistic-spectrum conditions, or hyper-development in psychotic-spectrum conditions, where language, causal thinking, social emotionality, and self-consciousness are specifically dysregulated ([@b500]; [@b44]; [@b42]).

The primary caveat regarding our interpretation of these data on neurogenetic sister-disorders is that some genomic alterations, such as VCFS duplications and Williams-syndrome region duplications, involve variable phenotypes that have yet to be characterized thoroughly in terms of behavioral phenotypes ([@b68]), or categorized in relation to formal psychiatric conditions. Moreover, the behavioral phenotypes of Smith--Magenis syndrome and Williams syndrome involve high levels of sociability, which contrast with notable levels of autistic spectrum phenotypes in their respective duplications but require further study to evaluate in terms of psychotic spectrum conditions such as phobias and mood lability. Further analyses of neurogenetic sister-disorders might usefully focus on dissecting genotype--phenotype correlations in such cases, also taking account of potentially causative variability in patterns of gene expression (e.g., [@b133]). An important consideration for such studies is the presence of superficial psychological similarities between autism and some manifestations of schizophrenia (such as childhood premorbid phenotypes and negative symptoms) that are not underlain by clearly shared biological causes and may thus obfuscate interpretation of phenotypes in terms of psychiatric conditions ([@b68]; [@b41]; [@b42]; [@b82]; [@b213]; see also [@b101]). Such similarities are especially problematic in studies of pediatric populations (e.g., [@b134]; [@b234]), given that children premorbid for schizophrenia spectrum conditions commonly exhibit deficits in social phenotypes (e.g., [@b132]) that can lead to incorrect diagnoses of autism.

To the extent that individuals with diametric genomic alterations exhibit diametric phenotypes, the genes mediating these phenotypes can be identified and characterized using a variety of methods including analyses of atypical deletions and single-gene mutations, mouse mutants, association studies relating variation in specific genes to salient traits, and studies of gene function and expression levels (e.g., [@b76]). In this study, we have analyzed how the salient genes have evolved along the lineages leading to humans and other primates, and detected the signals of positive selection on a notable number of the genes that are duplicated or deleted in neurogenetic sister-disorders. Based on combined information from studies of genetics, development, mouse models, and positive selection, several genes, including *GTPBP6, IL3RA, RAI1*, and *UFD1L*, can be highlighted as especially strong candidates for single genes whose altered expression may mediate the development of autistic and psychotic spectrum conditions, and social cognition more generally. To the extent that genes such as these have been subject to selection in the context of lower or higher levels of expression during primate evolution (e.g., [@b104]), their altered expression may thus be especially likely, compared to other genes, to cause maladaptive effects on neurodevelopment that affect social--behavioral phenotypes. This hypothesis is amenable to further study via analyses of the molecular and phenotypic effects of haplotypes or amino acids inferred as selected. Our finding that positive selection was especially prominent along the primate-origin lineage suggests that molecular-evolutionary changes underlying important features of complex social cognition were established well before separation of the human lineage. This hypothesis is consistent with complex patterns of genomic copy-number change in primates for PAR1 ([@b90]), the VCFS region ([@b193]; [@b7]), and the Williams-syndrome region ([@b4]), and with findings from comparative primatology (e.g., [@b246]), but it requires more-detailed comparative-genomic analyses.

Most generally, our study shows that how evolutionary perspectives and tools can provide novel insights into the genetic bases of human neurodevelopment and cognitive architecture, and complement studies based in psychiatry, neuroscience, and molecular and disease genetics. In particular, studies of positive selection can highlight genes or genomic regions with potential functional effects on medically relevant phenotypes, and models of cognitive architecture, derived from inferences regarding the evolution of human sociality, can structure the interpretation of psychiatric phenotypes and the search for their proximate causes. Such insights from evolutionary biology are based on integration of two large research areas, the evolution of humans and the etiology of human neurogenetic conditions, that have thus far developed in considerable isolation.
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